UGT1A1 and Hyperbilirubinemia: Two inhibitors that could potentially be applied in a clinical setting were selected for subsequent testing in vivo in the Ugt1a1-deficient Gunn rat, an animal model for inherited severe unconjugated hyperbilirubinemia.